Hypogalactosylation of serum IgG in patients with ANCA-associated systemic vasculitis
Open Access
- 28 June 2002
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 129 (1) , 183-190
- https://doi.org/10.1046/j.1365-2249.2002.01864.x
Abstract
The triad of small vessel vasculitides (SVV) comprise Wegener's granulomatosis (WG), microscopic polyangiitis (MPA) and Churg–Strauss syndrome (CS). All three are associated with presence of circulating IgG antineutrophil cytoplasm antibodies (ANCA) which target autoantigens contained, primarily, within neutrophil azurophilic granules. The widely accepted model of pathogenesis suggests that ANCA activate cytokine-primed neutrophils within the microvasculature, leading to by-stander damage to endothelial cells, and rapid escalation of inflammation with recruitment of mononuclear cells. Activation may be initiated, in vitro, by the coligation of the PR3 or MPO antigen, translocated to the cell surface, and FcγRIIa/FcγRIIIb receptors. This suggests that the IgG subclass profile of ANCA and, possibly, its glycosylation status could influence the inflammatory mechanisms activated. The glycosylation status of total IgG isolated from the sera of patients with WG (13), MPA (6) and CSS (1) was determined by analysis of the released oligosaccharides. A deficit in IgG galactosylation is demonstrated for all patient samples, compared to controls. The mean percentage values for the agalactosylated (G0) oligosaccharides were 57% (SD ± 9·71), 47% (SD ± 4·25) and 28% (SD ± 4·09) for WG, MPO and control samples, respectively. The G0 levels for polyclonal IgG isolated from the sera of both WG and MPA patients were significantly increased compared to controls (P < 0·0001). The major glycoform present therefore is agalactosylated (G0) IgG. In previous studies the G0 glycoform of IgG has been shown to bind and activate mannan binding lectin, and hence to activate the complement cascade, and to facilitate mannose receptor binding and the uptake of IgG complexes by macrophages and dendritic cells. Both of these activities could impact on the processing and presentation of self-antigens in autoimmune disease.Keywords
This publication has 42 references indexed in Scilit:
- Antineutrophil cytoplasm autoantibodies from patients with systemic vasculitis activate neutrophils through distinct signaling cascades: comparison with conventional Fcγ receptor ligationBlood, 2001
- Expression of GnTIII in a recombinant anti‐CD20 CHO production cell line: Expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FCγRIIIBiotechnology & Bioengineering, 2001
- The activation of the neutrophil respiratory burst by anti-neutrophil cytoplasm autoantibody (ANCA) from patients with systemic vasculitis requires tyrosine kinases and protein kinase C activationClinical and Experimental Immunology, 1999
- Anti-neutrophil cytoplasmic antibodies: Current diagnostic and pathophysiological potentialKidney International, 1994
- Nomenclature of Systemic VasculitidesArthritis & Rheumatism, 1994
- Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivoClinical and Experimental Immunology, 1994
- Activation of normal neutrophils by anti-neutrophil cytoplasm antibodiesClinical and Experimental Immunology, 1992
- Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils.Journal of Clinical Investigation, 1989
- GLYCOBIOLOGYAnnual Review of Biochemistry, 1988
- Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgGNature, 1985